Levodopa and Ro 4-4602 in psoriasis.
D000293:Adolescent; D000328:Adult; D000368:Aged; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001593:Benzyl Compounds / Q000627:therapeutic use; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy*; D012694:Serine / Q000627:therapeutic use*
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001593:Benzyl Compounds; D006834:Hydrazines; D012694:Serine; D004295:Dihydroxyphenylalanine